OS7.1 Impact of the addition of Rituximab to standard therapy with high dose methotrexate on health-related quality of life in primary central nervous system lymphoma patients | Zendy

AI Assistant Blog Pricing

OS7.1 Impact of the addition of Rituximab to standard therapy with high dose methotrexate on health-related quality of life in primary central nervous system lymphoma patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.